Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1266871.RAvT--vH23oeNolrOdR-rQGFlRiRJ6cE7ofTqr1pH0oKI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1266871.RAvT--vH23oeNolrOdR-rQGFlRiRJ6cE7ofTqr1pH0oKI130_assertion type Assertion NP1266871.RAvT--vH23oeNolrOdR-rQGFlRiRJ6cE7ofTqr1pH0oKI130_head.
- NP1266871.RAvT--vH23oeNolrOdR-rQGFlRiRJ6cE7ofTqr1pH0oKI130_assertion description "[These results suggest that tumor cells with methylated MGMT may undergo positive selection during TMZ treatment in the context of MMR deficiency.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266871.RAvT--vH23oeNolrOdR-rQGFlRiRJ6cE7ofTqr1pH0oKI130_provenance.
- NP1266871.RAvT--vH23oeNolrOdR-rQGFlRiRJ6cE7ofTqr1pH0oKI130_assertion evidence source_evidence_literature NP1266871.RAvT--vH23oeNolrOdR-rQGFlRiRJ6cE7ofTqr1pH0oKI130_provenance.
- NP1266871.RAvT--vH23oeNolrOdR-rQGFlRiRJ6cE7ofTqr1pH0oKI130_assertion SIO_000772 25724300 NP1266871.RAvT--vH23oeNolrOdR-rQGFlRiRJ6cE7ofTqr1pH0oKI130_provenance.
- NP1266871.RAvT--vH23oeNolrOdR-rQGFlRiRJ6cE7ofTqr1pH0oKI130_assertion wasDerivedFrom befree-2016 NP1266871.RAvT--vH23oeNolrOdR-rQGFlRiRJ6cE7ofTqr1pH0oKI130_provenance.
- NP1266871.RAvT--vH23oeNolrOdR-rQGFlRiRJ6cE7ofTqr1pH0oKI130_assertion wasGeneratedBy ECO_0000203 NP1266871.RAvT--vH23oeNolrOdR-rQGFlRiRJ6cE7ofTqr1pH0oKI130_provenance.